USE OF ATRIAL PEPTIDE ANTIBODIES, RECEPTOR ANTAGONISTS, AND ATRIAL PEPTIDE SYNTHESIS INHIBITORS IN CONTROLLING RENAL AND SYSTEMIC VASODILATION IN DIABETES MELLITUS

摘要

The invention relates to a method of treating diabetes-induced microangiopathy, glomerular hyperfiltration, glomerulopathy, and renal and systemic vasodilation in an animal by administration of a compound selected from the group consisting of anti-ANP antibodies, ANP receptor antagonists and ANP synthesis inhibitors.